Get started
Author

Aikaterini Berdiaki

Observed names: A Berdiaki, A. Berdiaki
Institution: University of Crete
ORCID: 0009-0001-3996-9877
Observed ORCID: 0009-0001-3996-9877
OpenAlex ID: A5001255911
Role of Receptor for Hyaluronic Acid-mediated Motility (RHAMM) in Low Molecular Weight Hyaluronan (LMWHA)-mediated Fibrosarcoma Cell Adhesion
2011 · Katerina Kouvidi, Aikaterini Berdiaki, et al. · Journal of Biological Chemistry · 137
PDF
Hyaluronan and Reactive Oxygen Species Signaling—Novel Cues from the Matrix?
2023 · Aikaterini Berdiaki, Monica Neagu, et al. · Antioxidants · 114
PDF
Cancer Microenvironment and Inflammation: Role of Hyaluronan
2015 · Dragana Nikitovic, Maria Tzardi, et al. · Frontiers in Immunology · 113
PDF
Extracellular Matrix Components and Mechanosensing Pathways in Health and Disease
2024 · Aikaterini Berdiaki, Monica Neagu, et al. · Biomolecules · 107
PDF
Role of the extracellular matrix in cancer‐associated epithelial to mesenchymal transition phenomenon
2017 · George Tzanakakis, Rafaela‐Maria Kavasi, et al. · Developmental Dynamics · 91
PDF
Lumican expression is positively correlated with the differentiation and negatively with the growth of human osteosarcoma cells
2007 · Dragana Nikitovic, Aikaterini Berdiaki, et al. · FEBS Journal · 84
HA metabolism in skin homeostasis and inflammatory disease
2017 · Rafaela-Maria Kavasi, Aikaterini Berdiaki, et al. · Food and Chemical Toxicology · 83
Proteoglycans—Biomarkers and Targets in Cancer Therapy
2018 · Dragana Nikitovic, Aikaterini Berdiaki, et al. · Frontiers in Endocrinology · 78
PDF
Lumican regulates osteosarcoma cell adhesion by modulating TGFβ2 activity
2011 · Dragana Nikitovic, Georgia Chalkiadaki, et al. · The International Journal of Biochemistry & Cell Biology · 77
Estradiol–estrogen receptor: A key interplay of the expression of syndecan‐2 and metalloproteinase‐9 in breast cancer cells
2008 · Olga Ch. Kousidou, Aikaterini Berdiaki, et al. · Molecular Oncology · 75
PDF
Enhancing Tumor Targeted Therapy: The Role of iRGD Peptide in Advanced Drug Delivery Systems
2024 · Dragana Nikitovic, Ekaterina Kukovyakina, et al. · Cancers · 73
Emerging roles of syndecan 2 in epithelial and mesenchymal cancer progression
2017 · Maria Mytilinaiou, Dragana Nikitovic, et al. · IUBMB Life · 73
Fibroblast growth factor-2 modulates melanoma adhesion and migration through a syndecan-4-dependent mechanism
2008 · Georgia Chalkiadaki, Dragana Nikitovic, et al. · The International Journal of Biochemistry & Cell Biology · 70
Lumican in Carcinogenesis—Revisited
2021 · Eirini-Maria Giatagana, Aikaterini Berdiaki, et al. · Biomolecules · 59
PDF
Role of telomere length in human carcinogenesis (Review)
2023 · Aristidis Tsatsakis, Tatiana Oikonomopoulou, et al. · International Journal of Oncology · 58
PDF
Insulin-Like Growth Factor and Epidermal Growth Factor Signaling in Breast Cancer Cell Growth: Focus on Endocrine Resistant Disease
2015 · Kallirroi Voudouri, Aikaterini Berdiaki, et al. · Analytical Cellular Pathology · 52
PDF
Glycosaminoglycans: Carriers and Targets for Tailored Anti-Cancer Therapy
2021 · Aikaterini Berdiaki, Monica Neagu, et al. · Biomolecules · 49
PDF
Biglycan Regulates MG63 Osteosarcoma Cell Growth Through a LPR6/β-Catenin/IGFR-IR Signaling Axis
2018 · John Aggelidakis, Aikaterini Berdiaki, et al. · Frontiers in Oncology · 46
PDF
Parathyroid hormone/parathyroid hormone-related peptide regulate osteosarcoma cell functions: Focus on the extracellular matrix (Review)
2016 · Dragana Nikitovic, Rafaela-Maria Kavasi, et al. · Oncology Reports · 41
PDF
Hyaluronan/RHAMM Interactions in Mesenchymal Tumor Pathogenesis
2014 · Katerina Kouvidi, Dragana Nikitovic, et al. · Advances in cancer research · 37
The Role of IGF/IGF-IR-Signaling and Extracellular Matrix Effectors in Bone Sarcoma Pathogenesis
2021 · George N. Tzanakakis, Eirini-Maria Giatagana, et al. · Cancers · 36
PDF
Hyaluronan/Hyaladherins - a Promising Axis for Targeted Drug Delivery in Cancer
2015 · Dragana Nikitovic, Katerina Kouvidi, et al. · Current Drug Delivery · 36
Low molecular weight heparin inhibits melanoma cell adhesion and migration through a PKCa/JNK signaling pathway inducing actin cytoskeleton changes
2011 · Georgia Chalkiadaki, Dragana Nikitovic, et al. · Cancer Letters · 36
Proteoglycans in the Pathogenesis of Hormone-Dependent Cancers: Mediators and Effectors
2020 · George Tzanakakis, Eirini-Maria Giatagana, et al. · Cancers · 34
PDF
The Motile Breast Cancer Phenotype Roles of Proteoglycans/Glycosaminoglycans
2014 · Dragana Nikitovic, Katerina Kouvidi, et al. · BioMed Research International · 33
PDF
Works count: 76
Citation count: 2,266
H-index: 30
I10-index: 49
Year
Topic
Type